ストックスクリーナーアプリを入手
65.81
3.09%
1.97
アフターアワーズ：
65.81
Cg Oncology Inc (CGON) 最新ニュース
Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - Barchart.com
CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - AOL.com
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know - AOL.com
Kynam Capital Cuts CG Oncology Holding: Q4 2025 Sale Details & ImpactNews and Statistics - IndexBox
This Biotech Stock Surged 135% but Just Saw a $44 Million Sell-Off. What Does This Mean for Investors? - Bitget
CGON Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Bank of America Securities Remains a Buy on CG Oncology, Inc. (CGON) - The Globe and Mail
CG Oncology (CGON) Expected to Announce Quarterly Earnings on Friday - MarketBeat
Quarterly Trades: Can CG Oncology Inc deliver consistent EPS growth2026 Key Highlights & Real-Time Price Movement Reports - baoquankhu1.vn
Why CG Oncology Stock Is Suddenly Losing Steam - TipRanks
CG Oncology, Inc. Hits New 52-Week High of $59.95 - Markets Mojo
Highs Report: What is the dividend yield of CG Oncology IncWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
Dividend Watch: Is CG Oncology Inc impacted by rising rates2026 Earnings Surprises & Community Trade Idea Sharing - baoquankhu1.vn
Will CG Oncology Inc outperform tech stocksEarnings Miss & Growth Oriented Trade Recommendations - baoquankhu1.vn
CG Oncology (NASDAQ:CGON) Director James Mulay Sells 1,964 Shares - MarketBeat
CG Oncology (NASDAQ: CGON) director sells 1,964 shares after option exercises - Stock Titan
Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Protagonist Therapeutics (PTGX) and CG Oncology, Inc. (CGON) - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Protagonist Therapeutics (PTGX), CG Oncology, Inc. (CGON) - The Globe and Mail
CG Oncology, Inc. $CGON Stake Increased by HighVista Strategies LLC - MarketBeat
Boothbay Fund Management LLC Has $3.81 Million Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology, Inc. $CGON Stake Lessened by Cinctive Capital Management LP - MarketBeat
CG Oncology (NASDAQ:CGON) Reaches New 52-Week HighShould You Buy? - MarketBeat
ArrowMark Colorado Holdings LLC Has $10.36 Million Holdings in CG Oncology, Inc. $CGON - MarketBeat
How Investors May Respond To CG Oncology (CGON) Expanding ATM Offering To Advance Cretostimogene BLA Efforts - simplywall.st
CG Oncology stock hits all-time high at 63.9 USD By Investing.com - Investing.com Nigeria
Is CG Oncology (CGON) Pricing Reflect Its Recent 131% Surge And Cancer Breakthrough Hopes - Yahoo Finance
Wall Street Analysts Believe CG Oncology, Inc. (CGON) Could Rally 157.91%: Here's is How to Trade - MSN
Mangrove Partners IM LLC Increases Stock Position in CG Oncology, Inc. $CGON - MarketBeat
Form 4 CG Oncology Inc For: 14 March - Investing.com
Form 4 CG Oncology Inc For: 14 March By Investing.com - Investing.com Australia
CG Oncology (NASDAQ: CGON) CEO net exercises options and increases share stake - Stock Titan
Rosalind Advisors Inc. Grows Holdings in CG Oncology, Inc. $CGON - MarketBeat
Is It Too Late To Consider CG Oncology (CGON) After A 143% One Year Surge? - simplywall.st
CG Oncology stock rallies nearly 32% in a week: Here is why - MSN
CG Oncology stock hits all-time high at 63.9 USD - Investing.com India
CG Oncology (NASDAQ:CGON) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
CG Oncology (CGON) Valuation Check After Strong Recent Share Price Momentum - simplywall.st
CG Oncology (NASDAQ:CGON) Sets New 52-Week HighHere's What Happened - MarketBeat
CG Oncology Conference: Credo Posts 75.5% CR in BOND-003, BLA Filing Targeted for 2026 - MarketBeat
JPMorgan Chase & Co. Has $9.18 Million Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
Replimune Stock Pre-Market (+16%): Sector Momentum Lifts Oncolytic Virus Peers - Trefis
Insider Trends: Is CG Oncology Inc exposed to currency risksJuly 2025 Trade Ideas & Capital Efficient Trade Techniques - baoquankhu1.vn
H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating - Finviz
CG Oncology (CGON) CEO nets 100,000 shares from option exercise - Stock Titan
10 Fastest Growing NASDAQ Stocks to Buy - Insider Monkey
Rafferty Asset Management LLC Lowers Stock Position in CG Oncology, Inc. $CGON - MarketBeat
Tech Rally: Will CG Oncology Inc stock recover after earningsInsider Buying & Risk Managed Investment Strategies - baoquankhu1.vn
Stock Traders Buy High Volume of Call Options on CG Oncology (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. $CGON Stock Holdings Trimmed by TD Asset Management Inc - MarketBeat
Lifesci Capital Predicts Stronger Earnings for CG Oncology - MarketBeat
CG Oncology (NASDAQ:CGON) Sets New 12-Month HighTime to Buy? - MarketBeat
CG Oncology, Inc. (CGON) Stock Analysis: A 39% Potential Upside in the Battle Against Bladder Cancer - DirectorsTalk Interviews
CG Oncology stock hits all-time high at 60.01 USD By Investing.com - Investing.com Australia
1.82%
大文字化:
|
ボリューム (24 時間):